This article has been updated to include comments from Illumina's conference call.

NEW YORK (GenomeWeb) – Illumina reported after the close of the market today that its first quarter 2015 revenues grew 28 percent year over year, and on a constant currency basis were up 33 percent.

The San Diego-based firm reported total Q1 2015 revenues of $538.6 million compared to $420.8 million in Q1 2014. It beat the average analyst estimate of $524.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.